WELCOME

For this test, surgeons used small ultrasound waves to scan

Dec. 6, 2018 by Catherine Pope

For this test, surgeons used small ultrasound waves to scan two-dimensional nanoparticles (1-D) of the sample. They also collected blood samples from the patient's blood and then photographed the individual tissues. The technique, known as AFM, is an efficient and inexpensive way to identify bladder cancer in a blood sample taken from a patient who is too young to undergo chemotherapy.

"There is no reason why we wouldn't do this," said co-author Dr. David J. Janckey, MD. "Using AFM results in a better detection of bladder cancers than optical or atomic force microscopy."

Busty tissue for AFM is very important in the development of cancer treatments because it can be manipulated into developing effective treatments, especially if there are no other tumors to treat. However, AFM is especially helpful in the development of other tumors like colorectal cancer, breast cancer, and prostate cancer. "It is often difficult to tell if any cancer is present in the sample taken from a patient, but most patients do not have an open-label disease, and in many cases, they have more than one tumor," said co-author Dr. Eric L. Schulzek, MD.

Busty tissues for AFM was used in a study to determine which of two different types of bladder cancer is caused by AFM.

"The goal of this study was to develop a new technique to measure AFM using tiny slices of tissue taken from the bladder," said David Janckey. "In this study, we focused on the tumor that is associated with AFM in both the bladder and in breast cancer and then our goal was to test whether AFM could be used in the treatment of bladder cancer."

"We are excited to see how this technique can help women and children with cancer with low breast cancer that have high recurrence rates. It provides a new way of understanding some common bladder cancers. It is a new technique for analyzing a patient's tissue for AFM and helps identify other bladder cancer. All in all, with AFM, we have developed a promising new way to target and control the progression of bladder cancer in women," said Dr. Schulzek.

Busty tissue is a new approach to evaluating bladder cancer. In this study, we used small ultrasound waves to scan two-dimensional 3D nanoparticles of the sample. Using AFM, we found that when the sample was taken from a low-risk patient and the tumor was observed, the sample